Table 2. As-needed and total budesonide/formoterol use by country.
Country | As-needed doses | Maintenance + as-needed inh/day | ||||
---|---|---|---|---|---|---|
inh/day | inh/week | 80/4.5 µg b.i.d. | 160/4.5 µg b.i.d. | 2 x 160/4.5 µg b.i.d. | ||
Belgium | No. | 621 | 5 | 482 | 134 | |
Median | 0.27 | 1.89 | 2.15 | 2.20 | 4.03 | |
Mean | 0.86 | 6.02 | 2.27 | 2.56 | 4.17 | |
Bulgaria | No. | 125 | 2 | 96 | 27 | |
Median | 0.25 | 1.75 | 2.07 | 2.14 | 3.32 | |
Mean | 0.57 | 3.99 | 2.08 | 2.34 | 3.45 | |
Czech Republic | No. | 349 | 2 | 286 | 61 | |
Median | 0.22 | 1.54 | 1.66 | 2.14 | 4.04 | |
Mean | 0.80 | 5.60 | 1.66 | 2.54 | 4.15 | |
Denmark | No. | 68 | 5 | 45 | 18 | |
Median | 0.20 | 1.40 | 2.09 | 2.12 | 4.03 | |
Mean | 0.86 | 6.02 | 2.01 | 2.32 | 4.00 | |
Germany | No. | 465 | 18 | 370 | 77 | |
Median | 0.35 | 2.45 | 2.07 | 2.10 | 4.00 | |
Mean | 0.87 | 6.09 | 3.15 | 2.43 | 3.91 | |
Greece | No. | 562 | 7 | 258 | 297 | |
Median | 0.27 | 1.89 | 2.08 | 2.20 | 4.00 | |
Mean | 0.83 | 5.81 | 2.08 | 2.86 | 4.08 | |
Hungary | No. | 475 | 3 | 302 | 170 | |
Median | 0.29 | 2.03 | 2.00 | 2.12 | 4.16 | |
Mean | 0.81 | 5.67 | 1.94 | 2.45 | 4.48 | |
Netherlands | No. | 335 | 8 | 250 | 77 | |
Median | 0.32 | 2.24 | 2.03 | 2.07 | 4.00 | |
Mean | 0.77 | 5.36 | 2.09 | 2.49 | 3.95 | |
Norway | No. | 418 | 6 | 281 | 131 | |
Median | 0.61 | 4.27 | 2.08 | 2.25 | 4.45 | |
Mean | 1.11 | 7.77 | 2.36 | 2.72 | 4.78 | |
Portugal | No. | 282 | 3 | 254 | 25 | |
Median | 0.04 | 0.28 | 1.76 | 2.00 | 3.81 | |
Mean | 0.30 | 2.10 | 1.52 | 2.13 | 3.56 | |
Sweden | No. | 417 | 24 | 278 | 115 | |
Median | 0.30 | 2.10 | 2.11 | 2.23 | 4.18 | |
Mean | 0.67 | 4.69 | 2.40 | 2.53 | 4.37 | |
United Kingdom | No. | 464 | 36 | 204 | 223 | |
Median | 0.58 | 4.06 | 2.43 | 2.20 | 4.18 | |
Mean | 1.38 | 9.66 | 2.69 | 2.67 | 4.50 | |
All | No. | 4,581 | 119 | 3,106 | 1,355 | |
Median | 0.30 | 2.10 | 2.11 | 2.14 | 4.05 | |
Mean | 0.83 | 5.81 | 2.48 | 2.53 | 4.27 |
b.i.d. = twice daily; inh = inhalation.